Skip to content

Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings

Efficacy and Safety of Nebulized Morphine Given at Two Different Doses Compared to Intravenous Morphine in Post-traumatic Acute Pain: a Randomized Controlled Double Blind Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02200185
Acronym
TIMORNEB
Enrollment
300
Registered
2014-07-25
Start date
2012-04-30
Completion date
2014-07-31
Last updated
2014-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Post-Traumatic Headache

Keywords

post traumatic pain, titrated morphine, nebulised morphine

Brief summary

The investigators test a different technique using morphine to improve pain relief in patient visiting the emergency department with acute trauma pain, for this we are comparing three different methods of morphine administration: * intravenous titrated morphine * low dose nebulized morphine and * high dose nebulized morphine

Detailed description

Trauma patients are frequent in emergency department settings, and often require urgent care. taking care of this patients consists on taking care of their pain and then the specific treatment of their traumatic lesions. actually, the most used medicine and most efficient one in treating pain is morphine, it's mechanism of action is by acting on receptors located on neuronal cell membranes and inhibit neurotransmitter release. The most applied administration root of morphine is by intravenous (IV) titration or IV continuous perfusion, but until now, there is no clear recommendation concerning the superiority of this root over other administration techniques such as nebulization. In this study we aimed to investigate the efficiency, the feasibility and the tolerance of three morphine administration roots in patients with acute traumatic pain and to clarify the most adequate one to apply in emergency department settings.

Interventions

DRUGIV titrated morphine

Intravenous morphine : 2 mg every 5 minutes by IV root and nebulized placebo: * SS nebulised : 5 ml SS nebulised over 10 minutes and repeated 3 times

DRUGLow dose nebulised morphine

10 mg morphine in 4 ml Serum Saline(SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

DRUGHigh dose nebulised morphine

20 mg morphine in 3 ml serum saline (SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
8 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* patients older than 8 years and less than 50 years * patients who consult emergency department for sever pain after an immediately trauma

Exclusion criteria

* Glasgow coma scale \<14 * inability to cooperate * hypotension with systolic blood pressure\< 90mmhg * bradypnea\<12cpm * SAO2\<90% * polytrauma * nasal trauma * rhinitis * nasal obstruction * allergy to opioids

Design outcomes

Primary

MeasureTime frameDescription
Pain resolution30 minutesprimary end point defined by the decrease in intensity pain objectified by a decline in visual analogy pain scale greater than or equal to 50% of its initial value

Secondary

MeasureTime frameDescription
side effects30 minutessecondary outcomes combine the occurrence of side effects requiring discontinuation of treatment such as: dizziness, dyspnea, cutaneous rush, vomiting, nausea and pruritus.

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026